Kolexia
Chouchane Mondher Pédiatrie
Chouchane Mondher
Pédiatrie
Hôpital François Mitterrand
Dijon, France
41 Activités
27 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Amyotrophie spinale Atrophie Amyotrophie Encéphalopathies Épilepsie Amyotrophies spinales infantiles Déficience intellectuelle Spasmes infantiles Crises épileptiques

Collaborateurs

Voir plus
Louis-Darmency Véronique
Louis-Darmency Véronique
Fondation Lenval - Hôpital pour enfants, Nice, France
Lemesle Martine
Lemesle Martine
Hôpital François Mitterrand, Dijon, France
Huet Frederic
Huet Frederic
Hôpital François Mitterrand, Dijon, France
Beauvais Katell
Beauvais Katell
Hôpital François Mitterrand, Dijon, France

Industries

Voir plus
Novartis
3 collaboration(s)
Dernière en 2023
B3TSI
2 collaboration(s)
Dernière en 2021
Eisai
2 collaboration(s)
Dernière en 2022
PASCALEO
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Effect of nusinersen after 3 years of treatment in 57 young children with SMA in terms of SMN2 copy number or type.
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie   21 décembre 2023
The emerging spectrum of fetal acetylcholine receptor antibody-related disorders (FARAD).
Brain : a journal of neurology   04 octobre 2023
What Is the Therapeutic Reference Range for Levetiracetam? Grand Round/A Case Study.
Therapeutic drug monitoring   17 mai 2022
The diagnostic rate of inherited metabolic disorders by exome sequencing in a cohort of 547 individuals with developmental disorders.
Molecular genetics and metabolism reports   18 octobre 2021
Expanded Access Program (EAP) for Nusinersen in Participants With Infantile-onset (Consistent With Type 1) Spinal Muscular Atrophy (SMA): Expanded Access Program (EAP) to Provide Nusinersen to Patients With Infantile-onset Spinal Muscular Atrophy (SMA)
Essai Clinique (Biogen)   01 avril 2021
West Syndrome Is an Exceptional Presentation of Pyridoxine- and Pyridoxal Phosphate-Dependent Epilepsy: Data From a French Cohort and Review of the Literature.
Frontiers in pediatrics   05 mars 2021
Effects of nusinersen after one year of treatment in 123 children with SMA type 1 or 2: a French real-life observational study.
Orphanet journal of rare diseases   12 juin 2020
P.379Fetal Acetylcholine Receptor Inactivation Syndrome (FARIS): A potentially treatable autoimmune disorder mimicking a wide range of genetic neuromuscular conditions
Neuromuscular disorders : NMD   01 octobre 2019
SMA THERAPIES I: P.168Treatment by nusinersen in spinal muscular atrophy type 1 patients older than 7 months: 14 months follow-up
Neuromuscular disorders : NMD   01 octobre 2018
Nusinersen in patients older than 7 months with spinal muscular atrophy type 1: A cohort study.
Neurology   29 août 2018